Reuters logo
REFILE-BRIEF-Neurovive says clinical development project KL1333 gets positive opinion on European orphan drug designation
November 8, 2017 / 10:20 AM / 12 days ago

REFILE-BRIEF-Neurovive says clinical development project KL1333 gets positive opinion on European orphan drug designation

(Fixes headline in original story)

Nov 8 (Reuters) - Neurovive Pharmaceutical AB

* Neurovive’s clinical development project KL1333 receives positive opinion on european orphan drug designation Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below